reduce basal insulin when starting glp-1 receptor agonist Agonists as Treatments for Type 2 Diabetes Current Insights, Advantages and Challenges
Description
P., Tate, C
E., Lee, N
doi: 10.1016/j.molmet.2024.101880 [DOI] [PMC free article] [PubMed] [Google Scholar] 244
The general class of GLP-1 drugs targets at least one of the reactions
Any reasonably skeptical person confronting this extraordinary list of effects must have several questions screaming to the front of their mind, including but not limited to: Are we sure GLP-1 drugs are this good
1012 Glucose when administered orally promotes significantly higher pancreatic insulin secretion than when it is administered intravenously, which is termed the incretin effect
